University of Illinois at Urbana-Champaign, Champaign, IL.
University of Pittsburgh, Pittsburgh, PA.
AMIA Annu Symp Proc. 2021 Jan 25;2020:554-563. eCollection 2020.
A longstanding issue with knowledge bases that discuss drug-drug interactions (DDIs) is that they are inconsistent with one another. Computerized support might help experts be more objective in assessing DDI evidence. A requirement for such systems is accurate automatic classification of evidence types. In this pilot study, we developed a hierarchical classifier to classify clinical DDI studies into formally defined evidence types. The area under the ROC curve for sub-classifiers in the ensemble ranged from 0.78 to 0.87. The entire system achieved an F1 of 0.83 and 0.63 on two held-out datasets, the latter consisting focused on completely novel drugs from what the system was trained on. The results suggest that it is feasible to accurately automate the classification of a sub-set of DDI evidence types and that the hierarchical approach shows promise. Future work will test more advanced feature engineering techniques while expanding the system to classify a more complex set of evidence types.
长期以来,药物相互作用知识库(DDI)存在一个问题,即它们之间不一致。计算机化的支持可能有助于专家在评估 DDI 证据时更加客观。此类系统的一个要求是准确自动对证据类型进行分类。在这项试点研究中,我们开发了一个分层分类器,将临床 DDI 研究分为正式定义的证据类型。在集合中的子分类器的 ROC 曲线下面积范围为 0.78 至 0.87。整个系统在两个保留数据集上的 F1 值分别为 0.83 和 0.63,后一个数据集专注于系统训练中从未涉及过的全新药物。结果表明,准确地自动分类 DDI 证据类型的子集是可行的,并且分层方法很有前途。未来的工作将测试更先进的特征工程技术,同时扩展系统以分类更复杂的证据类型集。